ReachMD Your single destination for free CMEs, medical news, & more. Be Part of the Knowledge. The compelling broadcast line-up of information and education runs 24/7.

ReachMD is a revolutionary healthcare communications and education network dedicated to helping busy healthcare professionals stay abreast of clinical research, treatment advances, expert opinions, and patient care strategies. Our unique, integrated network leverages peer-to-peer dialogs among medical experts to educate and inform listeners across a wide spectrum of topics. Listeners can 'tune in'

to dialogs on iHeart Radio and TuneIn, enjoy online streaming radio, download podcasts, participate in web-enabled segments on ReachMD.com, and access content through the MedicalRadio mobile app. ReachMD's popular format of peer-to-peer dialogs among medical experts hits the mark for busy clinicians: segments are succinct and typically run for 15 minutes, making it convenient for listeners to participate throughout the day and night wherever they are. Both certified and non-certified education are broadcast, with unique mobile access interfaces to receive CME credit. The custom series and medical industry features are the highlight of our platform, and more than 60 unique series cycle through our programming line-up, including Diabetes Discourse™, Lipid Luminations™, CDC Updates, NEJM Summaries, Grand Rounds Nation®, The FDA Voice, Medical Breakthroughs from Penn Medicine, Heart Matters, Women's Health Fridays™, and many more. ReachMD has the brightest minds today in broadcast media. We are healthcare media strategists and healthcare educationalists whose combined expertise makes the ReachMD broadcast network a one-of-a-kind healthcare enterprise.

Heading to Austin? Join program chairs Selina McGee, Justin Schweitzer, and Walter Whitley with keynotes Carlo Pelino an...
10/31/2025

Heading to Austin? Join program chairs Selina McGee, Justin Schweitzer, and Walter Whitley with keynotes Carlo Pelino and Osama Said. Free CE for optometrists. Register: https://ow.ly/KsRB50XgrSp

Welcome to MOD Live 2025! Join us and be a part of redefining the boundaries in optometry. We're taking clinical education a step further with 8.75...

10/30/2025

In this expert-led CME, Dr. Lieberman discusses how treatment burden—especially corticosteroids—shapes patient experience in FSGS.

You’ll also explore how to refine diagnosis, personalize treatment goals, and evaluate the real-world impact of emerging therapies.

Tap the link in bio to start learning.

10/30/2025

Advancing gMG Treatment: Emerging Therapies

Happening today! Get live insights on FcRn therapies in gMG at AANEM 2025—covering trial data, special populations, and ...
10/30/2025

Happening today! Get live insights on FcRn therapies in gMG at AANEM 2025—covering trial data, special populations, and more.

Register for the virtual broadcast: https://ow.ly/E4ZY50XjcSw
Sign up for an in-person seat: https://ow.ly/GRmN50XjcTs

This symposium, held during the 2025 AANEM Annual Meeting, explores the clinical integration of neonatal Fc receptor (FcRn) antagonists in the...

Tomorrow at AANEM: Your guide to FcRn therapies in gMG. Join expert faculty for a focused session on clinical applicatio...
10/29/2025

Tomorrow at AANEM: Your guide to FcRn therapies in gMG. Join expert faculty for a focused session on clinical application and key treatment considerations.

Reserve your spot to stream live: https://ow.ly/E4ZY50XjcSw
Be there in person: https://ow.ly/GRmN50XjcTs

This symposium, held during the 2025 AANEM Annual Meeting, explores the clinical integration of neonatal Fc receptor (FcRn) antagonists in the...

FcRn antagonists are reshaping gMG treatment. Get expert insight into mechanisms, trial data, and therapeutic decision-m...
10/26/2025

FcRn antagonists are reshaping gMG treatment. Get expert insight into mechanisms, trial data, and therapeutic decision-making at AANEM 2025—either at the event or on the live broadcast.

Register to attend virtually: https://ow.ly/oRxJ50XhReq
Join in person: https://ow.ly/Jqqf50XhRfb

This symposium, held during the 2025 AANEM Annual Meeting, explores the clinical integration of neonatal Fc receptor (FcRn) antagonists in the...

How do antibody profiles shape FcRn therapy in gMG? Find out with this expert-led symposium at AANEM 2025, available liv...
10/24/2025

How do antibody profiles shape FcRn therapy in gMG? Find out with this expert-led symposium at AANEM 2025, available live on-site or via livestream.

Sign up for online access: https://ow.ly/oRxJ50XhReq
Attend in person at AANEM: https://ow.ly/Jqqf50XhRfb

This symposium, held during the 2025 AANEM Annual Meeting, explores the clinical integration of neonatal Fc receptor (FcRn) antagonists in the...

Tune in now to hear expert faculty explore current therapies, emerging treatments, and the role of patient-reported outc...
10/23/2025

Tune in now to hear expert faculty explore current therapies, emerging treatments, and the role of patient-reported outcomes in shaping patient-centered care in FSGS.

This series also examines how evidence-based strategies can be applied across adult and pediatric patients to optimize monitoring and long-term outcomes.

Start listening: https://ow.ly/urGj50X8vXW

Managing patients with focal segmental glomerulosclerosis, or FSGS, can present certain challenges. FSGS is a serious, progressive condition that...

MOD Live 2025 is live and in person Nov 7–9 in Austin. 8.75 hours of free CE, faculty-led sessions, and practical cases ...
10/22/2025

MOD Live 2025 is live and in person Nov 7–9 in Austin. 8.75 hours of free CE, faculty-led sessions, and practical cases for optometrists. Save your seat: https://ow.ly/5ZPx50Xgryx

Welcome to MOD Live 2025! Join us and be a part of redefining the boundaries in optometry. We're taking clinical education a step further with 8.75 hours of FREE CE, expert panels, collaborative discussions, and numerous networking opportunities.
Gain insights from peers and experts in managing:

g...

For patients with FSGS, the diagnosis carries not just medical complexity but also uncertainty and life-altering day-to-...
10/21/2025

For patients with FSGS, the diagnosis carries not just medical complexity but also uncertainty and life-altering day-to-day challenges.

In this episode, you’ll hear directly from a patient about his journey and how these experiences highlight the importance of incorporating patient-reported outcomes into care and research.

Tune in now: https://ow.ly/facg50X8vKi

Managing patients with focal segmental glomerulosclerosis, or FSGS, can present certain challenges. FSGS is a serious, progressive condition that...

10/17/2025

KOL KO™: Oculoplastics Edition | Eyeing Up the Best in TED Management

  presents a clinical challenge—especially when it comes to tailoring treatment based on patient characteristics, age, a...
10/17/2025

presents a clinical challenge—especially when it comes to tailoring treatment based on patient characteristics, age, and disease progression.

This expert-led CME activity explores how to apply diagnostic strategies in both adult and pediatric patients, individualize treatment targets, and evaluate how emerging therapies impact health-related quality of life.

Learn how to integrate patient-centered decision-making into real-world FSGS care: https://ow.ly/QgNO50X8uOT

Focal segmental glomerulosclerosis (FSGS) is a prominent cause of kidney failure globally, necessitating dialysis for patient survival as the...

Address

1301 Virginia Drive Ste 300
Fort Washington, PA
19034

Opening Hours

Monday 8:30am - 5:30pm
Tuesday 8:30am - 5:30pm
Wednesday 8:30am - 5:30pm
Thursday 8:30am - 5:30pm
Friday 8:30am - 5:30pm

Website

http://reachmd.com/mobile.aspx, http://reachmd.com/twitter

Alerts

Be the first to know and let us send you an email when ReachMD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share